Noven Pharmaceuticals Inc is recalling Daytrana (methylphenidate transdermal system) patches because customer complaints regarding the product's delivery system exceeded acceptable limits. The recall affects 274, 110 patches from a single lot distributed nationwide. Daytrana is a prescription medication used to treat ADHD, and this defect may impact how the medication is administered through the skin.
A defective delivery system in a transdermal patch can lead to the medication being delivered inconsistently or not at all. This may result in the patient receiving an incorrect dose, potentially leading to a recurrence of symptoms or inadequate treatment of their medical condition.
You have 2 options:
Manufactured for Noven Therapeutics, LLC, Miami, FL 33186, By Noven Pharmaceuticals, Inc.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.